Первая клетка. И чего стоит борьба с раком до последнего

Shoemaker R. H. et al. Development of Human Tumor Cell Line Panels for Use in Disease-Oriented Drug Screening. Progress in Clinical and Biological Research. 276 (1988): 265–286.

Monks A. et al. Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines. Journal of the National Cancer Institute. 83 (1991): 757–766.

Monks A. et al. The NCI Anti-Cancer Drug Screen: A Smart Screen to Identify Effectors of Novel Targets. Anti-Cancer Drug Design. 12 (1997): 533–541.

Greve M. R. et al. The National Cancer Institute: Cancer Drug Discovery and Development Program. Seminars in Oncology. 19 (1992): 622–638.

Seok J. Genomic Responses in Mouse Models Poorly Mimic Human Inflammatory Diseases. PNAS. 110, no. 9 (2013): 3507–3512.

Begley C. G., Ellis L. M. Drug Development: Raise Standards for Preclinical Cancer Research. Nature. 483, no. 7391 (2012): 531–533.

Santarpia L. et al. Deciphering and Targeting Oncogenic Mutations and Pathways in Breast Cancer. Oncologist. 21 (2016): 1063–1078.

DeVita V. T., Jr., Chu E. A History of Cancer Chemotherapy. Cancer Research. 68 (2008): 8643–8653.

Sharpless N. E., Depinho R. A. The Mighty Mouse: Genetically Engineered Mouse Models in Cancer Drug Development. Nature Reviews Drug Discovery. 5 (2006): 741–754.

Ben-David U. et al. Patient-Derived Xenografts Undergo Mouse-Specific Tumor Evolution. Nature Genetics. 49, no. 11 (2017): 1567–1575.

Izumchenko E. et al. Patient-Derived Xenografts Effectively Capture Responses to Oncology Therapy in a Heterogeneous Cohort of Patients with Solid Tumors. Annals of Oncology. 28, no. 10 (2017): 2595–2605.

Tentler J. J. et al. Patient-Derived Tumour Xenografts as Models for Oncology Drug Development. Nature Reviews Clinical Oncology. 9, no. 6 (2012): 338–350.

Willyard C. The Mice with Human Tumours: Growing Pains for a Popular Cancer Model. Nature. 560, no. 7717 (2018): 156–157.

Van der Worp H. B. et al. Can Animal Models of Disease Reliably Inform Human Studies? PLOS Medicine. 7, no. 3 (2010): e1000245.

Francia G., Kerbel R. S. Raising the Bar for Cancer Therapy Models. Nature Biotechnology. 28 (2010): 561–562.

Ledford H. Cancer-Genome Study Challenges Mouse ‘Avatars.’ Grafting Human Cancer Cells into Mice Alters Tumour Evolution. Nature, October 9, 2017. doi:10.1038/nature.2017.22782.

NCI Awards Champions Oncology $ 2M SBIR Grant for Prostate Cancer Research. Genome Web. www.genomeweb.com/business-policy-funding/nci-awards-champions-oncology-2m-sbir-grant-prostate-cancer-research#.YbCuO9BBzIV

Cancer Drug Benefits Are Overhyped. Dying for a Cure, June 5, 2016.

http://dyingforacure.org/blogs/cancer-drug-benefits-overhyped/

Rubin E. H., Gilliland D. G. Drug Development and Clinical Trials – The Path to an Approved Cancer Drug. Nature Reviews Clinical Oncology. 9 (2012): 215–222.

Pharmaceutical Companies Acknowledge the Failure of Animal Models in Their Drug Development Process, and Write About This Openly in the Scientific Literature. For Life on Earth. www.forlifeonearth.org/wp-content/uploads/2013/05/Pharmaceutical-Company-Quotes2.pdf